DNA methylation biomarker for prostate cancer shows promise for accurately determining patient risk
Prostate-specific antigen (PSA) and other biomarkers are essential tools for diagnosing and monitoring prostate cancer. However, biomarkers to selectively identify patients with high risk of recurrence, those who might benefit ...
Dec 8, 2016
0
1